echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Many senior managers of pharmaceutical companies quit

    Many senior managers of pharmaceutical companies quit

    • Last Update: 2020-01-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In 2020, personnel changes in the pharmaceutical industry are still continuing, and senior managers of several pharmaceutical companies will leave On January 8, Tianjin Lisheng Pharmaceutical Co., Ltd., a listed company, announced that the board of directors had recently received a written job change report from Ma Feifei, the deputy general manager of the company Ma Feifei was no longer the deputy general manager of the company due to the job change In addition to Tianjin Lisheng Pharmaceutical Co., Ltd., since January 1, 2020, at least one pharmaceutical company has experienced executive turnover on average every day On January 1, Shenzhen Hanyu Pharmaceutical Co., Ltd announced that Yang Jun, the former vice president of the company, resigned from his post for personal reasons and will no longer hold any post in the company after leaving On the same day, Tianquan pharmaceutical announced that the board of directors had received the resignation report submitted by Wu Hailong, the financial director, on December 30, 2019, and the resignation took effect on December 30, 2019 Wu Hailong resigned from other positions in Tianquan pharmaceutical industry On January 2, fosci pharmaceutical announced the appointment of personnel in the new year, including the appointment of Shang Shoupeng as the general manager of the company, Wang Xinhai, LV Zhiying, Feng Xiaoyun, chaiguolin, Wang Yingchun as the deputy general manager of the company, among which LV Zhiying will also serve as the financial director and Secretary of the board of directors On January 2, Fang en pharmaceutical, a global clinical cro enterprise founded in 2007, released a news report, appointing senior international cro executive Zhen Ling as the co chairman and CEO On January 2, Jiangzhong pharmaceutical announced that Luo Juan, its former chief financial officer, had applied for resignation Before appointing a new chief financial officer, Li Xiaojun, the head of the company's financial department, acted as the chief financial officer On January 2, Puluo pharmaceutical announced that Zhu fangmeng, general manager of the company, Xu Xinliang, senior deputy general manager and Jin min, deputy general manager had submitted resignation reports, and all three applied for resignation due to work reasons On January 4, sunflower pharmaceutical announced that the board of directors had recently received the resignation report of Zhang Yanhui, the deputy general manager and financial director of the company, who said that he had applied to resign from relevant positions of the company due to personal reasons On January 6, Chunguang pharmaceutical announced that the board of directors had received the resignation report submitted by Wang Yin, deputy general manager of other positions on January 3, 2020, and the resignation took effect on January 6, 2020 In addition, it is reported that Zhao Biao, the former president of Yixintang, has ceased to be a director and executive of the company since the election in November 2019 It is speculated that he or she has resigned from the post of president The reason why the turnover trend continues is that, according to the statistics of Dongfang wealth choice, except for March, the number of executives leaving in other months of 2019 in pharmaceutical listed companies remained high Specifically, in May, the number of departures was the largest, up to 110; in April, August and September, the number of departures exceeded 50, of which the number of departures in April was 69 Specifically, in the past 2019, as many as 45 executives of multinational pharmaceutical companies have left, including AstraZeneca, Novartis, Lilly, Roche, Sanofi, BMS, GSK and other pharmaceutical companies In addition to multinational pharmaceutical companies, magic pharmaceutical, Jiangsu Wuzhong, Li Zhu group, Xinhua Pharmaceutical, Fauci pharmaceuticals, Hansen pharmaceutical, Tonghua Jinma, modern pharmaceutical, Hua Ren pharmaceutical, Nanjing medicine, Zhong Heng Group, Wei Guang biology, Tai Chi Group, Nanhua biology, Ling Rui pharmaceutical, essence medicine, Hainan marine medicine, Jinling pharmaceutical, Tongrentang national medicine, Tonghua Tongbao, sunflower medicine and so on The board chairman and other senior managers of domestic pharmaceutical enterprises have resigned Other data shows that since 2018, Pfizer, Sanofi, Novartis, GSK and other famous multinational pharmaceutical companies have cut nearly 20000 jobs worldwide In the face of frequent personnel changes, many industry insiders say that the pharmaceutical industry is in a recession, which is more difficult year by year Behind the pressure of the development of medicine is that with the improvement of living standards and the extension of life expectancy, more and more societies are entering the aging stage of population - the increasing medical expenses and the increasing pressure of medical insurance financing In order to balance financing and expenditure, maintain the sustainable development of medical insurance fund, medical insurance, as the buyer, increases the demand for cost control Although the pharmaceutical industry is hailed as a sunrise industry forever, the pursuit of biotechnology and medical health in the capital market is only second to that of it and Internet industry, but under the pressure of cost control, some health care related people told cypress blue that reducing drug prices is a global trend, and the United States is also introducing a series of laws to try to reduce drug prices.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.